RDNT Competitors & Alternatives
Compare RadNet Inc with similar stocks in the same industry
Diagnostics & Research
RDNT
Main Stock$77.94
Tradestie Score
38
Market Cap
$6.00B
Revenue Growth
0.2%
Analyst Upside
+21.4%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
QGEN
QIAGEN N.V.
|
$50.51
|
$10.04B | 27.3 | 38 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$345.80
|
$8.39B | 384.1 | 50 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$155.35
|
$7.81B | - | 52 | Compare |
|
BLLN
BLLN
|
$112.00
|
$5.49B | 124.9 | 42 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$16.27
|
$4.60B | 27.4 | 64 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$136.26
|
$3.98B | 28.7 | 57 | Compare |
|
LNTH
Lantheus Holdings, Inc
|
$101.62
|
$3.51B | 25.1 | 49 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$54.83
|
$3.26B | - | 51 | Compare |
|
VCYT
Veracyte, Inc.
|
$24.06
|
$2.85B | 16.8 | 47 | Compare |
|
SGRY
Surgery Partners, Inc. Common Stock
|
$26.73
|
$2.72B | - | 39 | Compare |
More RDNT Analysis
Data updated: Nov 10, 2026 | Industry: Diagnostics & Research (SIC 8071)
39 stocks in this industry